Aether Industries Limited (AETHER) Earnings Call Transcripts

16 earnings calls from June 2022 to July 31, 2026

NSEI IN Health Care Pharmaceuticals

Aether Industries Limited's Latest Earnings Call - Q4 FY2026

Aether Industries Limited reported its Q4 and FY '26 results, showing significant growth with a 38% YoY increase in revenue to INR 11,601 million and a 53% increase in EBITDA to INR 3,547 million. The EBITDA margin improved to 31% from 28% in FY '25. Despite a decline in Q4 revenue to INR 3,051 million from INR 3,188 million in Q3 due to one-off items, the company maintains a positive outlook. Management highlighted strong pricing in its large-scale manufacturing business, with a 20% YoY increase, and anticipates sustained demand and pricing. Guidance was not explicitly provided, but management indicated expectations of stable margins and significant contributions from new sites and products in FY '27.

Reported metrics

MetricValueContext
Revenue INR 11,601 million (beat) vs INR 8,406 million FY '25, +38% YoY
EBITDA INR 3,547 million (beat) vs INR 2,312 million FY '25, +53% YoY
EBITDA Margin 31% (beat) vs 28% FY '25
PAT INR 2,195 million (beat) vs INR 1,584 million FY '25, +39% YoY
Q4 Revenue INR 3,051 million (miss) vs INR 3,188 million Q3 FY '26

Guidance from management

Management expects stable margins with EBITDA between 29% to 30% and PAT around 19% to 20% for FY '27. No specific revenue guidance was provided, but significant contributions from Site 5 and new products are anticipated.

What management said

Yes. But we do have a natural hedge where we are importing certain products also from various parts of the world. So we have a natural hedge on this. We try to capitalize this as much as possible. However, our exports currently because of various uncertainties had been reduced by the CN customers, which had structurally put their Indian subsidiaries ahead. So we are selling to Indian subsidiaries and then they are ex...
— Rohan Desai, Q4 FY2026 earnings call
For the CM at least, which is an open cost P&L. So for that, it will not be -- it will not impact. But for LSM, there will be some delta wherein certain margins will go up and then it will subside.
— Faiz Nagariya, Q4 FY2026 earnings call

What analysts pressed on

Analysts questioned the impact of currency fluctuations on exports and the potential benefits. Concerns were also raised about the sustainability of pricing and demand given geopolitical disruptions. Management assured that pricing remains strong and demand steady.

Main topics on the call

Read the full Aether Industries Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Aether Industries Limited

Aether Industries Limited (AETHER) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on NSEI and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 16 calls on record spanning June 17, 2022 to July 31, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 16 Aether Industries Limited earnings call transcripts on record, spanning June 17, 2022 to July 31, 2026. Based on this history, Aether Industries Limited reports quarterly. The most recent call on file is dated July 31, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
AETHER
Exchange
NSEI
Country
IN
Sector
Health Care
Industry
Pharmaceuticals
Calls on record
16
First call
June 17, 2022
Most recent
July 31, 2026
Reporting cadence
quarterly
Quarter Date
Q1 FY2027 Jul 31, 2026 Read transcript
Q4 FY2026 May 15, 2026 Read transcript
Q1 FY2026 Jul 24, 2025 Read transcript
Q4 FY2025 May 3, 2025 Read transcript
Q3 FY2025 Jan 17, 2025 Read transcript
Q2 FY2025 Oct 18, 2024 Read transcript
Q1 FY2025 Jul 19, 2024 Read transcript
Q4 FY2024 May 21, 2024 Read transcript
Q3 FY2024 Feb 1, 2024 Read transcript
Q2 FY2024 Oct 31, 2023 Read transcript
Q1 FY2024 Jul 26, 2023 Read transcript
Q4 FY2023 May 8, 2023 Read transcript
Q3 FY2023 Jan 20, 2023 Read transcript
Q2 FY2023 Nov 14, 2022 Read transcript
Q1 FY2023 Jul 26, 2022 Read transcript
Q4 FY2022 Jun 17, 2022 Read transcript